Can learning to cope boost Crohn's treatment? new trial aims to find out

NCT ID NCT06512597

Recruiting now Disease control Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This study tests whether adding a structured coping skills program to standard biologic medication improves emotional well-being and disease remission in people with early Crohn's disease. 170 adults with active Crohn's for less than 5 years will receive either the coping program or a general support program, both delivered via telemedicine. The goal is to see if combining psychological care with medication leads to better long-term outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: IBD Coping Strategies Program (behavioral intervention)
What this could lead to: If it works, this could show that combining psychological support with standard medication leads to better emotional and physical outcomes for people with Crohn's disease.
What could go wrong: This is a relatively small, early-stage trial (170 people) testing a behavioral intervention, so results may not apply to everyone. The coping program may not provide additional benefit over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN'S DISEASE

Contacts and locations

Locations

Icahn School of Medicine at Mount Sinai
RECRUITING

New York, New York, 10029, United States
New York Gastroenterology Associates
RECRUITING

New York, New York, 10128, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.